1. 427PPhase I study of AMG 211/MEDI-565 administered as continuous intravenous infusion (cIV) for relapsed/refractory gastrointestinal (GI) adenocarcinoma. (23rd October 2018) Authors: Moek, K L; Fiedler, W M; von Einem, J C; Verheul, H M; Seufferlein, T; de Groot, D J; Heinemann, V; Kebenko, M; Menke-van der Houven van Oordt, C W; Ettrich, T J; Rasmussen, E; Bogner, P; Sable, B; Stienen, S; de Vries, E G E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗